Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

  1. Sferra, T.J.
  2. Merta, T.
  3. Neely, M.
  4. Murta De Oliveira, C.
  5. Lassaletta, A.
  6. Fortuny Guasch, C.
  7. Dorr, M.B.
  8. Winchell, G.
  9. Su, F.-H.
  10. Perko, S.
  11. Fernsler, D.
  12. Waskin, H.
  13. Holden, S.R.
Aldizkaria:
Journal of the Pediatric Infectious Diseases Society

ISSN: 2048-7207,  2048-7193

Argitalpen urtea: 2023

Alea: 12

Zenbakia: 6

Orrialdeak: 334-341

Mota: Artikulua

DOI: 10.1093/JPIDS/PIAD031 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus